turnover for twice a day

Merck just reported twice a day Isentress sales up 34% to $313m FOR THE QUARTER!

4*313M = US$1.25B per year and rising...

http://www.merck.com/newsroom/news-release-archive/financial/2011_0203.html

prediction of over $2B by 2015

and isentress will stay twice a day

http://www.reuters.com/article/2010/11/29/us-merck-isentress-sb-idUSTRE6AS4DD20101129

just a reminder
about 25% of pts on isentress become resistant to it with 1 year
about 35% of pts on isentress become resistant to it with 2 years

http://www.hivandhepatitis.com/recent/2008/072508_a.html

...........................................................

Biotechnology company Avexa Limited (ASX:AVX) announced today that a series of in-vitro experiments have
shown that ATC maintains potent antiviral activity against strains of HIV which are resistant to the new class of
integrase inhibitors, including the recently approved Merck HIV integrase inhibitor, raltegravir/isentress.
...
No resistance to ATC has been identified after 96 weeks of dosing